Sushrut Waikar, MD
Norman G. Levinsky Professor of Medicine
Boston University School of Medicine
Dept of Medicine
Nephrology

MD, Yale University
MPH, Harvard School of Public Health




Sushrut S. Waikar, MD, MPH received a BA in English and Neuroscience at Amherst College, his MD at Yale, and an MPH at Harvard. He is the Norman G. Levinsky Professor of Medicine at Boston University School of Medicine and Chief of Nephrology at Boston Medical Center. Dr. Waikar's research interests and active projects include biomarker discovery/validation, non-invasive biomarkers of kidney histopathology, renal functional reserve, kidney functional MRI, oxalate nephropathy, and clinical trials in CKD. He is a Principal Investigator of several NIH grants including the Kidney Precision Medicine Project (UH3DK114915), the Chronic Kidney Disease of Uncertain Etiology Consortium (U01DK130060), the Boston University Kidney and Medical Engineering Program (R25DK128858), Metablomics of Renal Functional Reserve (R21DK119751), and Biomarkers of Chronic Kidney Disease (U01DK085660).

Section Chief
Boston University School of Medicine
Medicine
Nephrology




Role of Amphiregulin in kidney fibrosis- DK121200
09/15/2019 - 08/31/2024 (Co-Investigator)
Washington University NIH-NIDDK
5R01DK121200-02

Electronic Tools to Increase Recognition and Improve Primary Care Management…
09/16/2019 - 07/31/2023 (Co-Investigator)
Brigham & Women's NIH-NIDDK
5R01DK116898-03

Kidney Physiology Phenotyping in the Kidney Precision Medicine Project
07/01/2020 - 06/30/2022 (PI)
University of Washington, Seattle NIH-NIDDK

ADVANCING MULTIPARAMETRIC KIDNEY FUNCTIONAL MRI TO PHENOTYPE INDIVIDUALS WITH CKD
07/01/2020 - 06/30/2022 (PI)
University of Washington, Seattle NIH-NIDDK
5U2CDK114886-04

Harvard Chronic Kidney Disease Research Biopsy Center
09/01/2019 - 06/30/2022 (PI)
Brigham & Women's NIH-NIDDK

Chan Zuckerberg Science Initiative- CZI
07/01/2019 - 06/30/2022 (PI)
Washington University Chan Zuckerberg Init

The Boston University Kidney and Medical Engineering Program (BU-KIDMEP)
04/01/2021 - 02/28/2022 (PI)
National Institutes of Health/DHHS/NIH
1R25DK128858-01

(Prenotification) Chronic Kidney Disease Biomarker Discovery and Validation Consortium
09/16/2019 - 07/31/2021 (PI)
Brigham & Women's NIH-NIDDK
5U01DK085660-10

Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older…
09/16/2019 - 04/30/2021 (Co-Investigator)
Northern California Institute for Research and Education NIH-NIA

Metabolomics and Renal Functional Reserve
09/15/2019 - 01/31/2021 (PI)
NIH-NIDDK

Showing 10 of 12 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2021 Discovery Science Collaborative for CKDu 1U01DK130060-01
2021 The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) 1R25DK128858-01
2021 Harvard Chronic Kidney Disease Research Biopsy Center 5UH3DK114915-05
2020 Metabolomics and Renal Functional Reserve 5R21DK119751-02
2020 Metabolomics and Renal Functional Reserve 5R21DK119751-02
2020 Harvard Chronic Kidney Disease Research Biopsy Center 5UH3DK114915-04
2019 Metabolomics and Renal Functional Reserve 1R21DK119751-01
2019 Harvard Chronic Kidney Disease Research Biopsy Center 4UH3DK114915-03
2019 Biomarkers of Chronic Kidney Disease 5U01DK085660-10 46
2018 Harvard Chronic Kidney Disease Research Biopsy Center 5UG3DK114915-02 1
Showing 10 of 43 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Liu J, Tio MC, Verma A, Schmidt IM, Ilori TO, Knauf F, Mc Causland FR, Waikar SS. Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022 Jan 01; 107(1):e281-e292.View Related Profiles. PMID: 34390334
     
  2. Koopman JJE, Rennke HG, McMahon GM, Waikar SS, Costenbader KH. Associations between renal deposits of complement factors, disease activity and loss of renal function in lupus nephritis. J Clin Pathol. 2021 Dec 30. PMID: 34969783
     
  3. Kilgallon JL, Gannon M, Burns Z, McMahon G, Dykes P, Linder J, Bates DW, Waikar S, Lipsitz S, Baer HJ, Samal L. Multicomponent intervention to improve blood pressure management in chronic kidney disease: a protocol for a pragmatic clinical trial. BMJ Open. 2021 Dec 22; 11(12):e054065. PMID: 34937722
     
  4. Kelly Y, Mistry K, Ahmed S, Shaykevich S, Desai S, Lipsitz S, Leaf D, Mandel E, Robinson E, McMahon G, Czarnecki P, Charytan D, Waikar S, Mendu M. Controlled Study of Decision-Making Algorithms for Kidney Replacement Therapy Initiation in Acute Kidney Injury. Clin J Am Soc Nephrol. 2021 Dec 15. PMID: 34911731
     
  5. Butler CR, Appelbaum PS, Ascani H, Aulisio M, Campbell CE, de Boer IH, Dighe AL, Hall DE, Himmelfarb J, Knight R, Mehl K, Murugan R, Rosas SE, Sedor JR, O'Toole JF, Tuttle KR, Waikar SS, Freeman M. A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project. Am J Kidney Dis. 2021 Dec 03. PMID: 34871700
     
  6. Perkovic V, Blackorby A, Cizman B, Carroll K, Cobitz AR, Davies R, DiMino TL, Jha V, Johansen KL, Lopes RD, Kler L, Macdougall IC, McMurray JJV, Meadowcroft AM, Obrador GT, Solomon S, Taft L, Wanner C, Waikar SS, Wheeler DC, Wiecek A, Singh AK. The ASCEND-ND trial: Study design and participant characteristics. Nephrol Dial Transplant. 2021 Dec 02. PMID: 34865143
     
  7. Causland FRM, Ravi KS, Curtis KA, Kibbelaar ZA, Short SAP, Singh AT, Correa S, Waikar SS. A randomized controlled trial of two dialysate sodium concentrations in hospitalized hemodialysis patients. Nephrol Dial Transplant. 2021 Nov 18. PMID: 34792161
     
  8. Jain A, Huang R, Lee J, Jawa N, Lim YJ, Guron M, Abish S, Boutros PC, Brudno M, Carleton B, Cuvelier GDE, Gunaratnam L, Ho C, Adeli K, Kuruvilla S, Lajoie G, Liu G, Nathan PC, Rod Rassekh S, Rieder M, Waikar SS, Welch SA, Weir MA, Winquist E, Wishart DS, Zorzi AP, Blydt-Hansen T, Zappitelli M, Urquhart B. A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol. Can J Kidney Health Dis. 2021; 8:20543581211057708. PMID: 34820133; PMCID: PMC8606978; DOI: 10.1177/20543581211057708;
     
  9. Schmidt IM, Sarvode Mothi S, Wilson PC, Palsson R, Srivastava A, Onul IF, Kibbelaar ZA, Zhuo M, Amodu A, Stillman IE, Rennke HG, Humphreys BD, Waikar SS. Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease. Clin J Am Soc Nephrol. 2022 Jan; 17(1):27-37.View Related Profiles. PMID: 34759008
     
  10. Gutiérrez OM, Shlipak MG, Katz R, Waikar SS, Greenberg JH, Schrauben SJ, Coca S, Parikh CR, Vasan RS, Feldman HI, Kimmel PL, Cushman M, Bonventre JV, Sarnak MJ, Ix JH. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study. Am J Kidney Dis. 2021 Nov 06. PMID: 34752914
     
Showing 10 of 233 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 233 publications over 18 distinct years, with a maximum of 45 publications in 2021

YearPublications
20051
20064
20073
20086
20096
20103
20119
201215
201315
201413
201512
201617
201715
201811
201923
202034
202145
20221
Contact for Mentoring:
Waikar's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department